NO890261L - Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater. - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.Info
- Publication number
- NO890261L NO890261L NO89890261A NO890261A NO890261L NO 890261 L NO890261 L NO 890261L NO 89890261 A NO89890261 A NO 89890261A NO 890261 A NO890261 A NO 890261A NO 890261 L NO890261 L NO 890261L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutic active
- tetrahydropyridine derivatives
- analogy procedure
- active tetrahydropyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3801659A DE3801659A1 (de) | 1988-01-21 | 1988-01-21 | Tetrahydropyridin - derivate |
Publications (2)
Publication Number | Publication Date |
---|---|
NO890261D0 NO890261D0 (no) | 1989-01-20 |
NO890261L true NO890261L (no) | 1989-07-24 |
Family
ID=6345698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO89890261A NO890261L (no) | 1988-01-21 | 1989-01-20 | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater. |
Country Status (22)
Country | Link |
---|---|
US (1) | US5422353A (fi) |
EP (1) | EP0325263B1 (fi) |
JP (1) | JP2967989B2 (fi) |
KR (1) | KR890011841A (fi) |
AT (1) | ATE80873T1 (fi) |
AU (1) | AU615978B2 (fi) |
CS (1) | CS274508B2 (fi) |
DD (1) | DD283378A5 (fi) |
DE (2) | DE3801659A1 (fi) |
DK (1) | DK24889A (fi) |
ES (1) | ES2043896T3 (fi) |
FI (1) | FI890277A (fi) |
GR (1) | GR3005838T3 (fi) |
HU (1) | HU202495B (fi) |
IL (1) | IL89015A (fi) |
NO (1) | NO890261L (fi) |
NZ (1) | NZ227662A (fi) |
PL (1) | PL157626B1 (fi) |
PT (1) | PT89500B (fi) |
SU (1) | SU1628856A3 (fi) |
YU (1) | YU12189A (fi) |
ZA (1) | ZA89424B (fi) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4985437A (en) * | 1986-12-17 | 1991-01-15 | Glaxo Group Limited | Medicaments |
JPH01233270A (ja) * | 1988-03-14 | 1989-09-19 | Shionogi & Co Ltd | ピロリンおよびテトラヒドロピリジン誘導体 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT287711B (de) * | 1968-06-25 | 1971-02-10 | Boehringer Sohn Ingelheim | Verfahren zur Herstellung von neuen 1-Alkyl-1,2,5,6-tetrahydro-3-pyridylmethyl-carbonsäureestern sowie deren Säureadditionssalzen und quaternären Ammoniumverbindungen |
US4467095A (en) * | 1969-02-10 | 1984-08-21 | Fmc Corporation | Anticholinergic compounds |
-
1988
- 1988-01-21 DE DE3801659A patent/DE3801659A1/de not_active Withdrawn
-
1989
- 1989-01-18 SU SU894613246A patent/SU1628856A3/ru active
- 1989-01-19 FI FI890277A patent/FI890277A/fi not_active Application Discontinuation
- 1989-01-19 PL PL1989277260A patent/PL157626B1/pl unknown
- 1989-01-19 DD DD89325137A patent/DD283378A5/de not_active IP Right Cessation
- 1989-01-19 ZA ZA89424A patent/ZA89424B/xx unknown
- 1989-01-19 NZ NZ227662A patent/NZ227662A/en unknown
- 1989-01-19 YU YU00121/89A patent/YU12189A/xx unknown
- 1989-01-20 IL IL89015A patent/IL89015A/xx unknown
- 1989-01-20 DE DE8989100918T patent/DE58902310D1/de not_active Expired - Lifetime
- 1989-01-20 EP EP89100918A patent/EP0325263B1/de not_active Expired - Lifetime
- 1989-01-20 JP JP1011774A patent/JP2967989B2/ja not_active Expired - Fee Related
- 1989-01-20 CS CS39189A patent/CS274508B2/cs unknown
- 1989-01-20 ES ES89100918T patent/ES2043896T3/es not_active Expired - Lifetime
- 1989-01-20 AT AT89100918T patent/ATE80873T1/de not_active IP Right Cessation
- 1989-01-20 HU HU89237A patent/HU202495B/hu not_active IP Right Cessation
- 1989-01-20 KR KR1019890000561A patent/KR890011841A/ko not_active Application Discontinuation
- 1989-01-20 DK DK024889A patent/DK24889A/da unknown
- 1989-01-20 NO NO89890261A patent/NO890261L/no unknown
- 1989-01-20 PT PT89500A patent/PT89500B/pt not_active IP Right Cessation
- 1989-01-20 AU AU28615/89A patent/AU615978B2/en not_active Ceased
-
1992
- 1992-09-30 GR GR920402172T patent/GR3005838T3/el unknown
-
1993
- 1993-10-29 US US08/145,264 patent/US5422353A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CS274508B2 (en) | 1991-04-11 |
HU202495B (en) | 1991-03-28 |
JP2967989B2 (ja) | 1999-10-25 |
PT89500A (pt) | 1989-10-04 |
FI890277A (fi) | 1989-07-22 |
NZ227662A (en) | 1991-04-26 |
IL89015A0 (en) | 1989-08-15 |
PT89500B (pt) | 1994-03-31 |
PL277260A1 (en) | 1989-10-16 |
NO890261D0 (no) | 1989-01-20 |
ATE80873T1 (de) | 1992-10-15 |
AU615978B2 (en) | 1991-10-17 |
ES2043896T3 (es) | 1994-01-01 |
CS39189A2 (en) | 1990-08-14 |
EP0325263A1 (de) | 1989-07-26 |
SU1628856A3 (ru) | 1991-02-15 |
JPH01224361A (ja) | 1989-09-07 |
PL157626B1 (en) | 1992-06-30 |
ZA89424B (en) | 1990-09-26 |
KR890011841A (ko) | 1989-08-22 |
US5422353A (en) | 1995-06-06 |
DK24889A (da) | 1989-07-22 |
HUT50122A (en) | 1989-12-28 |
AU2861589A (en) | 1989-07-27 |
DE58902310D1 (de) | 1992-10-29 |
DK24889D0 (da) | 1989-01-20 |
DD283378A5 (de) | 1990-10-10 |
EP0325263B1 (de) | 1992-09-23 |
FI890277A0 (fi) | 1989-01-19 |
GR3005838T3 (fi) | 1993-06-07 |
IL89015A (en) | 1993-02-21 |
DE3801659A1 (de) | 1989-07-27 |
YU12189A (en) | 1991-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO167384C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-aralkylpiperidinmethanolderivater. | |
NO875082L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridinoksimer. | |
NO902411D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer. | |
NO880182D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater. | |
NO165922C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av hexahydro-8-hydroxy-2,6-methano-2h-kinolizin-3-(4h)-on og beslektede forbindelser. | |
NO166080C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner. | |
NO171412C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater | |
NO171909C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater | |
NO166130C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-pyridonderivater. | |
NO891114L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater. | |
NO167802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater. | |
NO171211C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner | |
NO890261L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater. | |
NO306468B1 (no) | Nye fosfolipid-derivater, deres fremstilling, legemiddel inneholdende derivatene og derivatenes anvendelse | |
NO862390D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater. | |
NO162468C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 12-amino-pyridazino (4[,5[;3,4)-pyrrolo-( 2,1-a)-isokinolinderivater. | |
NO168247C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner. | |
NO893768D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 2,7-diamino-1,2,3,4-tetrahydronaftalenderivater. | |
NO166715C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cytorodin s derivater. | |
NO170331C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive acyleringsprodukter av bis(2-imidazolin-2-ylhydrazoner)av 9,10-antracen- dikarboksaldehyd | |
NO890328D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 4-amino-2,3-disubstituert-6,7-dihydro-5h-1-pyrindinderivater. | |
NO170541C (no) | Analogiframgangsmaate for framstilling av terapeutisk aktive 1,5-benzotiazepinderivater | |
NO170017C (no) | Analogiframgangsmaate for framstilling av terapeutisk aktive 1,5-benzotiazepinderivater | |
NO170545C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 6,21-dimethyl-19-nor-pregna-diener | |
NO921307D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3,5-tritianderivater |